Upadacitinib Improves Outcomes in Biologic-Refractory Ankylosing Spondylitis

back pain (change in NRS, -4.9 and -4.6), and functional indices (change in BASFI, -3.8 and -3.7), respectively. Imaging outcomes showed sustained …
Source: back pain

Leave a Reply

Your email address will not be published. Required fields are marked *